National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 56077 [2022-19674]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19730 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(Ks) and Conference support (R13) Review.
Date: October 25, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tianhong Wang, Ph.D.,
MD, Scientific Review Officer, National
Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health,
6707 Democracy Blvd., Bethesda, MD 20892,
(301) 435–1189, wangt3@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 7, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19674 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Cancer Institute; Notice of
Meeting
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: September 28, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Acting Director’s Update, NCI
Updates and Legislative Update.
Place: National Institutes of Health, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Amy Williams, Acting
Director, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 9000
Rockville Pike, Building 31, Room 10A28,
Bethesda, MD 20892, (240) 781–3406,
williaam@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 8, 2022.
Melanie J. Pantoja,
Program Analyst, sOffice of Federal Advisory
Committee Policy.
[FR Doc. 2022–19729 Filed 9–12–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
56077
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genomic Fields to Enhance Diversity.
Date: November 7, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Computational Genomics and Data
Science.
Date: November 17, 2022.
Time: 3:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3189, Bethesda, MD 20892, (301) 435–
1580, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; T32 Genomic Training.
Date: November 18, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3189, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Page 56077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting of the
National Institute of Biomedical Imaging and Bioengineering Special
Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Career Development (Ks) and
Conference support (R13) Review.
Date: October 25, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tianhong Wang, Ph.D., MD, Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy Blvd.,
Bethesda, MD 20892, (301) 435-1189, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 7, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19674 Filed 9-12-22; 8:45 am]
BILLING CODE 4140-01-P
